Dosimetric predictors of radiation-induced lung injury.
暂无分享,去创建一个
[1] R. Clough,et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. , 2001, International journal of radiation oncology, biology, physics.
[2] K Hirata,et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. , 1998, European journal of cancer.
[3] P Schraube,et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. , 1995, International journal of radiation oncology, biology, physics.
[4] Z. Liao,et al. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. , 1997, International journal of radiation oncology, biology, physics.
[5] W. Curran,et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Spencer,et al. Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity. , 1999, Seminars in radiation oncology.
[7] John B. West,et al. Respiratory Physiology - the Essentials , 1979 .
[8] Lawrence B Marks,et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. , 2002, International journal of radiation oncology, biology, physics.
[9] M T Munley,et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.
[10] R. Jaszczak,et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] G. Gagliardi,et al. Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis. , 2002, International journal of radiation oncology, biology, physics.
[12] Andrew Jackson,et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. , 2002, International journal of radiation oncology, biology, physics.
[13] R. Makuch,et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P Baas,et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] R. Jaszczak,et al. The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests , 2000, Cancer.
[16] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[17] J A Purdy,et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.
[18] J. Battista,et al. In-field and out-of-field effects in partial volume lung irradiation in rodents: possible correlation between early dna damage and functional endpoints. , 2000, International journal of radiation oncology, biology, physics.
[19] P. Kirchner,et al. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. , 1980, The Journal of thoracic and cardiovascular surgery.
[20] Ž. Vujašković,et al. TGF-beta, radiation-induced pulmonary injury and lung cancer. , 2000, International journal of radiation biology.
[21] R K Ten Haken,et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.
[22] L. Boersma,et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] G J Kutcher,et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] D. Gandara,et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M T Munley,et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. , 1997, International journal of radiation oncology, biology, physics.
[26] T. J. Robnett,et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. , 2000, International journal of radiation oncology, biology, physics.
[27] J. Smith,et al. Lung cancer in patients with borderline lung functions--zonal lung perfusion scans at presentation and lung function after high dose irradiation. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] P. Okunieff,et al. Radiation pneumonitis and early circulatory cytokine markers. , 2002, Seminars in radiation oncology.
[29] K. Shin,et al. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-analysis of a radiation therapy oncology group (RTOG) protocol , 1993 .
[30] Z. Liao,et al. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. , 1997, International journal of radiation oncology, biology, physics.
[31] L. Boersma,et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. , 2000, International journal of radiation oncology, biology, physics.